92 related articles for article (PubMed ID: 2836211)
1. Modulation of atrial natriuretic peptide-induced cGMP accumulation by [Arg8]vasopressin in the cultured renal epithelial cell line, LLC-PK1.
Neuser D; Stasch JP; Morich FJ
Eur J Pharmacol; 1988 Feb; 146(2-3):341-4. PubMed ID: 2836211
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.
Leitman DC; Agnost VL; Catalano RM; Schröder H; Waldman SA; Bennett BM; Tuan JJ; Murad F
Endocrinology; 1988 Apr; 122(4):1478-85. PubMed ID: 2894298
[TBL] [Abstract][Full Text] [Related]
3. Specific binding activities and cyclic GMP responses by atrial natriuretic polypeptide in kidney epithelial cell line (LLC-PK1).
Inui K; Saito H; Matsukawa Y; Nakao K; Morii N; Imura H; Shimokura M; Kiso Y; Hori R
Biochem Biophys Res Commun; 1985 Oct; 132(1):253-60. PubMed ID: 2415124
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line.
Nambi P; Whitman M; Gessner G; Aiyar N; Crooke ST
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8492-5. PubMed ID: 2430290
[TBL] [Abstract][Full Text] [Related]
5. Diuretics modify [Arg8]vasopressin-stimulated cAMP but not atrial natriuretic peptide-stimulated cGMP formation in renal cells.
Kanda K; Miyamoto N; Seo H; Ogawa K; Hatano T; Matsui N
Eur J Pharmacol; 1991 Jan; 192(1):153-9. PubMed ID: 1645672
[TBL] [Abstract][Full Text] [Related]
6. Effect of brain natriuretic peptide on cyclic GMP accumulation in a kidney epithelial cell line (LLC-PK1).
Iwata T; Inui K; Nakao K; Imura H; Matsuo H; Hori R
Eur J Pharmacol; 1989 Jan; 159(3):321-3. PubMed ID: 2537742
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides.
Ozaki J; Shimizu H; Hashimoto Y; Itoh H; Nakao K; Inui K
Eur J Pharmacol; 1999 Apr; 370(3):307-12. PubMed ID: 10334507
[TBL] [Abstract][Full Text] [Related]
8. Modulation of ANP receptor-mediated cGMP accumulation by atrial natriuretic peptides and vasopressin in A10 vascular smooth muscle cells.
Bellemann P; Neuser D
J Recept Res; 1988; 8(1-4):407-17. PubMed ID: 2898530
[TBL] [Abstract][Full Text] [Related]
9. Functional evidence for an apical ANP receptor in LLC-PK1 kidney epithelial cells.
Hashimoto Y; Ozaki J; Yasuhara M; Hori R; Suga S; Itoh H; Nakao K; Inui K
Eur J Pharmacol; 1994 Aug; 268(3):443-5. PubMed ID: 7805770
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells.
Bouley R; Breton S; Sun T; McLaughlin M; Nsumu NN; Lin HY; Ausiello DA; Brown D
J Clin Invest; 2000 Nov; 106(9):1115-26. PubMed ID: 11067864
[TBL] [Abstract][Full Text] [Related]
11. ADH resistance of LLC-pk1 cells caused by overexpression of cAMP-phosphodiesterase type-IV.
Yamaki M; McIntyre S; Murphy JM; Swinnen JV; Conti M; Dousa TP
Kidney Int; 1993 Jun; 43(6):1286-97. PubMed ID: 8391097
[TBL] [Abstract][Full Text] [Related]
12. Isozymes of cyclic-3',5'-nucleotide phosphodiesterases in renal epithelial LLC-PK1 cells.
Rassier ME; McIntyre SJ; Yamaki M; Takeda S; Lin JT; Dousa TP
Kidney Int; 1992 Jan; 41(1):88-99. PubMed ID: 1343559
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide inhibits the phosphoinositide hydrolysis in murine Leydig tumor cells.
Khurana ML; Pandey KN
Mol Cell Biochem; 1996 May; 158(2):97-105. PubMed ID: 8817470
[TBL] [Abstract][Full Text] [Related]
14. A novel LLC-PK1 renal epithelial cell mutant impaired in in vivo down-regulation of cAMP-mediated hormonal response.
Jans DA; Resink TJ; Hemmings BA
Arch Biochem Biophys; 1991 Mar; 285(2):377-81. PubMed ID: 1716864
[TBL] [Abstract][Full Text] [Related]
15. Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase.
Ishii K; Chang B; Kerwin JF; Wagenaar FL; Huang ZJ; Murad F
J Pharmacol Exp Ther; 1991 Jan; 256(1):38-43. PubMed ID: 1671098
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: role of cGMP and heme oxygenase-1.
Polte T; Hemmerle A; Berndt G; Grosser N; Abate A; Schröder H
Free Radic Biol Med; 2002 Jan; 32(1):56-63. PubMed ID: 11755317
[TBL] [Abstract][Full Text] [Related]
17. Effects of atrial natriuretic peptide and sodium nitroprusside on epidermal growth factor-stimulated wound repair in rabbit corneal epithelial cells.
Zhang Y; Islam M; Akhtar RA
Curr Eye Res; 2000 Sep; 21(3):748-56. PubMed ID: 11120563
[TBL] [Abstract][Full Text] [Related]
18. Extracellular cGMP inhibits transepithelial sodium transport by LLC-PK1 renal tubular cells.
Chevalier RL; Fang GD; Garmey M
Am J Physiol; 1996 Feb; 270(2 Pt 2):F283-8. PubMed ID: 8779888
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic factor effects on cyclic nucleotides in a human renal cell line.
Cole FE; Rovigatti U; Iwata T; Vaughn J; Frohlich ED
Hypertension; 1989 Jun; 13(6 Pt 2):799-803. PubMed ID: 2567705
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic peptides inhibit mesangial cell production of endothelin induced by arginine vasopressin.
Kohno M; Horio T; Ikeda M; Yokokawa K; Fukui T; Yasunari K; Murakawa K; Kurihara N; Takeda T
Am J Physiol; 1993 Apr; 264(4 Pt 2):F678-83. PubMed ID: 8386472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
